TrialAnti-cancer drugs2017

Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.

Georgina Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.